Quick Answer
Curanex Pharmaceuticals Inc reported Net Income Loss of -$4.23 million for the year ending 2025.
- Curanex Pharmaceuticals Inc showed a decrease of -1,068.8% in Net Income Loss from 2024 to 2025.
- This data is from Curanex Pharmaceuticals Inc's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2024 to 2025 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: -$4.23 million | Fiscal year 2024: -$361.5 thousand.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: